TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

Bibliográfalaš dieđut
Váldodahkkit:	Feldmann, M, Maini, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2003

Geahča maid

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2003)

TNF alpha as a therapeutic target in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1994)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1995)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2002)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
Dahkki: Maini, R, et al.
Almmustuhtton: (1994)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1992)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1994)

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Dahkki: Williams, R, et al.
Almmustuhtton: (2007)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
Dahkki: Feldmann, M
Almmustuhtton: (1996)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2011)

TNFα - A pivotal role in rheumatoid arthritis?
Dahkki: Brennan, F, et al.
Almmustuhtton: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
Dahkki: Brennan, F, et al.
Almmustuhtton: (1992)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2001)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2001)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
Dahkki: Maini, R, et al.
Almmustuhtton: (1997)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Dahkki: Maini, R, et al.
Almmustuhtton: (1993)

TNF as a therapeutic target
Dahkki: Bondeson, J, et al.
Almmustuhtton: (2000)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
Dahkki: Elliott, M, et al.
Almmustuhtton: (1995)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
Dahkki: Elliott, M, et al.
Almmustuhtton: (1995)

TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Dahkki: Bystrom, J, et al.
Almmustuhtton: (2016)

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2008)

Development of anti-TNF therapy for rheumatoid arthritis.
Dahkki: Feldmann, M
Almmustuhtton: (2002)

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
Dahkki: Taylor, P, et al.
Almmustuhtton: (2004)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
Dahkki: Maini, R, et al.
Almmustuhtton: (2000)

Molecular therapeutic targets in rheumatoid arthritis.
Dahkki: Sacre, S, et al.
Almmustuhtton: (2005)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
Dahkki: Maini, R, et al.
Almmustuhtton: (1995)

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
Dahkki: Taylor, P
Almmustuhtton: (2001)

Rheumatoid arthritis: introduction.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1998)

Rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1996)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
Dahkki: Brennan, F, et al.
Almmustuhtton: (1989)

Cytokine therapy in rheumatoid arthritis.
Dahkki: Maini, R, et al.
Almmustuhtton: (1996)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
Dahkki: Feldman, M, et al.
Almmustuhtton: (1998)

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Dahkki: Taylor, P
Almmustuhtton: (2010)

The role of cytokines in the pathogenesis of rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1999)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1995)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2004)

Role of cytokines in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1996)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
Dahkki: Taylor, P, et al.
Almmustuhtton: (2009)

How does infliximab work in rheumatoid arthritis?
Dahkki: Maini, R, et al.
Almmustuhtton: (2002)